NCT00979862: Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma |
|
|
| Completed | 1 | 47 | US | Cediranib Maleate, AZD2171, AZD2171 Maleate, Recentin, Cilengitide, EMD 121974, EMD-121974, Laboratory Biomarker Analysis | National Cancer Institute (NCI) | Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Neoplasm | 05/12 | 02/14 | | |
NCT01122888: Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme |
|
|
| Terminated | 1 | 41 | US | Cilengitide, EMD 121974, EMD-121974, Clinical Observation, Laboratory Biomarker Analysis | National Cancer Institute (NCI) | Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Solid Neoplasm, Recurrent Adult Brain Neoplasm | 09/12 | 04/15 | | |
